Ascend Laboatories,llc C/O UPS Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Ascend Laboatories,llc C/O UPS Pharmaceutical Import Records from India — 4 Products, $950.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ascend Laboatories,llc C/O UPS — Pharmaceutical Importer Profile (2026) | 4 Products, $950.0K Trade | TransData Nexus

Ascend Laboatories,llc C/O UPS

Pharmaceutical Importer · United States · Cardiovascular Focus · $950.0K Total Trade · DGFT Verified

Ascend Laboatories,llc C/O UPS is a pharmaceutical importer based in United States with a total trade value of $950.0K across 4 products in 2 therapeutic categories. Based on 19 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ascend Laboatories,llc C/O UPS sources from 1 verified Indian supplier, with Alkem Laboratories Limited accounting for 100.0% of imports.

Ascend Laboatories,llc C/O UPS — Import Portfolio & Supplier Network

Ascend Laboatories,llc C/O UPS import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ascend Laboatories,llc C/O UPS?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Alkem Laboratories Limited	$2.3M	112	100.0%

Ascend Laboatories,llc C/O UPS sources from 1 verified Indian supplier across 58 distinct formulations. The sourcing is highly concentrated — Alkem Laboratories Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Mycophenolic acid dr tabs USP 360MG 120s bno;24120566,24120582(8597 packs)	$114.6K	3
Gabapentin 300MG capsules(1000s) bno;24120599(6624 packs)	$89.6K	3
Cholestyramine fos USP 4grams (42 sachet) jar bno;23123771,23123772,23123773,23124007 (8039 packs	$86.0K	3
Myco acid dr TAB USP 180MG 120s bno;24120229(9019 packs)	$64.9K	3
Ezetimibe tablets USP 10MG(500s)bno;23123914,24120001(7152 packs	$63.7K	3
Lurasidone hcl tabs 40MG(30s)bno;23123887,23123888(21816 packs	$60.2K	3
Gabapentin 300MG capsules (1000s)bno;24120599(3840 packs)	$51.6K	3
Finasteride tabs USP 5MG(90s)Each	$50.0K	1
Finasteride tabs USP 5MG(1000s)Each	$50.0K	1
Amlodipine besylate tablets 5MG(500s)bno;23143714(6528 packs)	$50.0K	1
Amlodipine TAB. 10MG(90s) bno;23143746(18864 packs)	$50.0K	1
Amlodipine besylate tablets 10MG(500s) bno;23143830(3276 packs)	$50.0K	1
Metoprolol succ.er tabs USP 100MG 500s bno;23143651,23143791(1359 packs)	$50.0K	1
Metoprolol succ.er tabs USP 100MG 100s bno;23143649(2808 packs)	$50.0K	1
Metoprolol succ.er tabs USP 25MG 100s bno;23143589,23143590(20016 packs)	$50.0K	1

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Amlodipine	Cardiovascular	$350.0K	7	0.0%	6
2	Metoprolol	Cardiovascular	$250.0K	5	0.0%	7
3	Ras	Ayurvedic & Herbal Products	$200.0K	4	0.1%	11
4	Atorvastatin	Cardiovascular	$150.0K	3	0.0%	6

Ascend Laboatories,llc C/O UPS imports 4 pharmaceutical products across 2 categories into United States totaling $950.0K.

Ascend Laboatories,llc C/O UPS — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Ascend Laboratories, LLC, operating under the name Ascend Laboratories, LLC C/O UPS, is a pharmaceutical importer and buyer based in the United States. The company is headquartered at 6200 New Cut Road, Fairdale, Kentucky 40118. Ascend Laboratories specializes in the importation of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily sourced from India. Their product portfolio encompasses a range of therapeutic categories, with a notable emphasis on cardiovascular medications and Ayurvedic & herbal products. The company's strategic focus on these therapeutic areas aligns with the growing demand for both conventional and alternative medicine options in the U.S. market.

2Distribution Network

While specific details about Ascend Laboratories' warehouse locations and logistics capabilities are not publicly disclosed, the company's operations are managed from their headquarters in Fairdale, Kentucky. This central location facilitates efficient distribution across the United States. The use of UPS (United Parcel Service) as part of their operational address suggests a reliance on established logistics networks to manage the importation and distribution of pharmaceutical products. This partnership likely enables Ascend Laboratories to leverage UPS's extensive infrastructure for timely and secure delivery of their products nationwide.

3Industry Role

Ascend Laboratories functions as a pharmaceutical importer and buyer within the U.S. pharmaceutical supply chain. By sourcing finished pharmaceutical formulations from Indian manufacturers, the company plays a crucial role in introducing these products to the U.S. market. Their focus on importing finished dosage forms, rather than active pharmaceutical ingredients (APIs) or bulk drugs, positions them as a key intermediary between international manufacturers and U.S. consumers. This role is vital in meeting the diverse therapeutic needs of the U.S. population, particularly in areas where there is a demand for both conventional and alternative medicine options.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ascend Laboatories,llc C/O UPS

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Ascend Laboratories demonstrates a high degree of supplier concentration, with all 19 shipments from India sourced exclusively from Alkem Laboratories Limited. This single-source dependency indicates a strategic choice to establish a strong, reliable partnership with a leading Indian pharmaceutical manufacturer. The substantial total import value of $950K USD across 19 shipments suggests a stable and ongoing relationship between Ascend Laboratories and Alkem Laboratories Limited. However, this concentration also presents potential risks, such as supply chain disruptions due to geopolitical events, regulatory changes, or operational challenges faced by the supplier. Diversifying the supplier base could mitigate these risks and enhance supply chain resilience.

2Supply Chain Resilience

The resilience of Ascend Laboratories' supply chain is closely tied to the stability and reliability of Alkem Laboratories Limited. Given the exclusive sourcing arrangement, any disruptions at Alkem's end could significantly impact Ascend's ability to meet market demand. The lack of publicly available information regarding backup suppliers or alternative sourcing strategies suggests a potential vulnerability in the supply chain. Additionally, the concentration of shipments from a single supplier may expose Ascend Laboratories to risks associated with shipping routes and regulatory compliance. Ensuring that Alkem Laboratories Limited adheres to international quality standards and maintains robust shipping practices is essential for mitigating these risks.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal framework for drug approval, manufacturing, and importation. For pharmaceutical imports, the FDA requires that all foreign drug establishments register with the agency and list all their drug products intended for U.S. distribution. This process ensures that imported drugs meet the same standards for quality, safety, and effectiveness as domestically produced drugs. The FDA also conducts inspections and enforces compliance with these regulations to protect public health.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. All foreign drug establishments must register with the FDA and list their drug products intended for U.S. distribution. This registration process ensures that imported drugs meet the same standards for quality, safety, and effectiveness as domestically produced drugs. Additionally, the FDA requires that imported drugs comply with Good Manufacturing Practice (GMP) standards. While the FDA does not directly recognize certifications such as EU GMP, WHO GMP, or PIC/S, it assesses compliance with GMP through its own inspections and evaluations. Therefore, Indian exporters must ensure that their manufacturing facilities adhere to FDA's GMP requirements to facilitate the importation of their products into the U.S. market.

Ascend Laboatories,llc C/O UPS — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Ascend Laboratories' focus on importing cardiovascular medications and Ayurvedic & herbal products aligns with the growing demand for both conventional and alternative medicine options in the U.S. market. Cardiovascular diseases remain a leading cause of morbidity and mortality in the United States, driving the need for effective treatments. Simultaneously, there is an increasing consumer interest in natural and holistic health solutions, contributing to the popularity of Ayurvedic and herbal products. By sourcing these products from India, Ascend Laboratories leverages the country's established reputation in pharmaceutical manufacturing and its rich tradition in herbal medicine. This strategic product focus enables Ascend Laboratories to cater to a diverse consumer base seeking both scientifically validated and alternative therapeutic options.

2Sourcing Profile

Ascend Laboratories' sourcing strategy is centered on importing finished pharmaceutical formulations from India, with a particular emphasis on cardiovascular medications and Ayurvedic & herbal products. This approach allows the company to offer a diverse product portfolio that meets the therapeutic needs of the U.S. market. By partnering exclusively with Alkem Laboratories Limited, Ascend Laboratories ensures a consistent supply of high-quality products. This sourcing strategy reflects a commitment to quality and reliability, as Alkem Laboratories Limited is a well-established manufacturer in the Indian pharmaceutical industry. The focus on finished formulations, rather than active pharmaceutical ingredients (APIs) or bulk drugs, indicates a strategic decision to streamline operations and focus on the distribution of ready-to-market products.

Seller's Guide — How to Become a Supplier to Ascend Laboatories,llc C/O UPS

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Ascend Laboratories by offering complementary products or by demonstrating the ability to meet Ascend's quality and supply chain requirements. Diversifying the supplier base could enhance Ascend Laboratories' competitive position and resilience in the market. For Indian exporters, this presents an opportunity to establish partnerships with a U.S. importer that has a focus on

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Ascend Laboatories,llc C/O UPS

What products does Ascend Laboatories,llc C/O UPS import from India?

Ascend Laboatories,llc C/O UPS imports 4 pharmaceutical products across 2 categories. Top imports: Amlodipine ($350.0K), Metoprolol ($250.0K), Ras ($200.0K), Atorvastatin ($150.0K).

Who supplies pharmaceuticals to Ascend Laboatories,llc C/O UPS from India?

Ascend Laboatories,llc C/O UPS sources from 1 verified Indian suppliers. The primary supplier is Alkem Laboratories Limited (100.0% of imports, $2.3M).

What is Ascend Laboatories,llc C/O UPS's total pharmaceutical import value?

Ascend Laboatories,llc C/O UPS's total pharmaceutical import value from India is $950.0K, based on 19 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ascend Laboatories,llc C/O UPS focus on?

Ascend Laboatories,llc C/O UPS imports across 2 categories. The largest: Cardiovascular (78.9%), Ayurvedic & Herbal Products (21.1%).

Get Full Ascend Laboatories,llc C/O UPS Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Ascend Laboatories,llc C/O UPS

Ascend Laboatories,llc C/O UPS — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Ascend Laboatories,llc C/O UPS?

What Formulations Does Ascend Laboatories,llc C/O UPS Import?

What Products Does Ascend Laboatories,llc C/O UPS Import?

Top Products by Import Value

Ascend Laboatories,llc C/O UPS Therapeutic Categories — 2 Specializations